Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-28

Clinical Trial Update: A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of fesoterodine in men at high risk for overactive bladder/detrusor overactivity after robotic-assisted radical prostatecto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fesoterodine (fesoterodine)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Prostate Adenocarcinoma | Phase 4 | Status: COMPLETED